[(2S,3S,5R)-5-{4-amino-3-[(4-fluorophenyl)sulfanyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate

ID: ALA4437838

Chembl Id: CHEMBL4437838

PubChem CID: 153295312

Max Phase: Preclinical

Molecular Formula: C16H17FN6O5S2

Molecular Weight: 456.48

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1c(Sc1ccc(F)cc1)nn2[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1

Standard InChI:  InChI=1S/C16H17FN6O5S2/c17-8-1-3-9(4-2-8)29-16-13-14(18)20-7-21-15(13)23(22-16)12-5-10(24)11(28-12)6-27-30(19,25)26/h1-4,7,10-12,24H,5-6H2,(H2,18,20,21)(H2,19,25,26)/t10-,11-,12+/m0/s1

Standard InChI Key:  DVBGRGPNKCSMEL-SDDRHHMPSA-N

Alternative Forms

  1. Parent:

    ALA4437838

    ---

Associated Targets(Human)

ATG7 Tchem Ubiquitin-like modifier-activating enzyme ATG7 (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 456.48Molecular Weight (Monoisotopic): 456.0686AlogP: 0.57#Rotatable Bonds: 6
Polar Surface Area: 168.47Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.33CX Basic pKa: 3.44CX LogP: 1.15CX LogD: 1.15
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.48Np Likeness Score: -0.57

References

1.  (2018)  Atg7 inhibitors and the uses thereof, 

Source